Rare-disease drug developer (hereditary angioedema)
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Louis Bacon / Moore | 52 | Added +20% | 1,021,869 | $8,512,169 | 0.2% |
| Steve Cohen / Point72 | 75 | Added +63% | 426,306 | $3,551,129 | 0.0% |
| Bridgewater | 55 | Added +74% | 854,235 | $7,115,778 | 0.0% |
| Paul Tudor Jones / Tudor | 61 | Trimmed -5% | 269,760 | $2,247,101 | 0.0% |
| Trade date | Who | Type | Amount | |
|---|---|---|---|---|
| 2026-07-10 | Gilbert Cisneros CA31 | BUY | $1,001 - $15,000 | PTR |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.